Clinical Characteristics and Survival of Korean Idiopathic Pulmonary Arterial Hypertension Patients Based on Vasoreactivity
We aimed to identify a vasoreactive subset of patients with idiopathic pulmonary arterial hypertension (IPAH) in Korea and to show their clinical characteristics and prognosis. Data on patients who were diagnosed with IPAH at Asan Medical Center between January 1994 and March 2013 were retrospective...
Saved in:
Published in | Journal of Korean medical science Vol. 29; no. 12; pp. 1665 - 1671 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
The Korean Academy of Medical Sciences
01.12.2014
대한의학회 |
Subjects | |
Online Access | Get full text |
ISSN | 1011-8934 1598-6357 1598-6357 |
DOI | 10.3346/jkms.2014.29.12.1665 |
Cover
Abstract | We aimed to identify a vasoreactive subset of patients with idiopathic pulmonary arterial hypertension (IPAH) in Korea and to show their clinical characteristics and prognosis. Data on patients who were diagnosed with IPAH at Asan Medical Center between January 1994 and March 2013 were retrospectively collected. Acute vasodilator testing was performed with inhaled nitric oxide during diagnostic right heart catheterization. A positive acute response was defined as a reduction in mean pulmonary arterial pressure (PAP) ≥10 mmHg to an absolute level of mean PAP <40 mmHg without a decrease in cardiac output. Among a total of 60 IPAH patients included for analysis, 9 (15%) showed a positive acute response to acute vasodilator testing. Acute responders showed significantly lower peak velocity of a tricuspid regurgitation jet on echocardiography (4.1±0.3 m/s vs. 4.6±0.6 m/s; P=0.01) and significantly lower mean PAP hemodynamically (47±10 mmHg vs. 63±17 mmHg; P=0.003) than non-responders at baseline. The survival rate of acute responders was 88% at 1, 3, 5, and 10 yr, respectively, which was significantly higher than that of non-responders (85%, 71%, 55%, and 40%, respectively; P=0.029). In conclusion, Korean IPAH patients with vasoreactivity showed better baseline hemodynamic features and survival than those without vasoreactivity. |
---|---|
AbstractList | We aimed to identify a vasoreactive subset of patients with idiopathic pulmonary arterial hypertension (IPAH) in Korea and to show their clinical characteristics and prognosis. Data on patients who were diagnosed with IPAH at Asan Medical Center between January 1994 and March 2013 were retrospectively collected. Acute vasodilator testing was performed with inhaled nitric oxide during diagnostic right heart catheterization. A positive acute response was defined as a reduction in mean pulmonary arterial pressure (PAP) ≥10 mmHg to an absolute level of mean PAP <40 mmHg without a decrease in cardiac output. Among a total of 60 IPAH patients included for analysis, 9 (15%) showed a positive acute response to acute vasodilator testing. Acute responders showed significantly lower peak velocity of a tricuspid regurgitation jet on echocardiography (4.1±0.3 m/s vs. 4.6±0.6 m/s;
P
=0.01) and significantly lower mean PAP hemodynamically (47±10 mmHg vs. 63±17 mmHg;
P
=0.003) than non-responders at baseline. The survival rate of acute responders was 88% at 1, 3, 5, and 10 yr, respectively, which was significantly higher than that of non-responders (85%, 71%, 55%, and 40%, respectively;
P
=0.029). In conclusion, Korean IPAH patients with vasoreactivity showed better baseline hemodynamic features and survival than those without vasoreactivity. We aimed to identify a vasoreactive subset of patients with idiopathic pulmonary arterial hypertension (IPAH) in Korea and to show their clinical characteristics and prognosis. Data on patients who were diagnosed with IPAH at Asan Medical Center between January 1994 and March 2013 were retrospectively collected. Acute vasodilator testing was performed with inhaled nitric oxide during diagnostic right heart catheterization. A positive acute response was defined as a reduction in mean pulmonary arterial pressure (PAP) ≥10 mmHg to an absolute level of mean PAP <40 mmHg without a decrease in cardiac output. Among a total of 60 IPAH patients included for analysis, 9 (15%) showed a positive acute response to acute vasodilator testing. Acute responders showed significantly lower peak velocity of a tricuspid regurgitation jet on echocardiography (4.1±0.3 m/s vs. 4.6±0.6 m/s; P=0.01) and significantly lower mean PAP hemodynamically (47±10 mmHg vs. 63±17 mmHg; P=0.003) than non-responders at baseline. The survival rate of acute responders was 88% at 1, 3, 5, and 10 yr, respectively, which was significantly higher than that of non-responders (85%, 71%, 55%, and 40%, respectively; P=0.029). In conclusion, Korean IPAH patients with vasoreactivity showed better baseline hemodynamic features and survival than those without vasoreactivity.We aimed to identify a vasoreactive subset of patients with idiopathic pulmonary arterial hypertension (IPAH) in Korea and to show their clinical characteristics and prognosis. Data on patients who were diagnosed with IPAH at Asan Medical Center between January 1994 and March 2013 were retrospectively collected. Acute vasodilator testing was performed with inhaled nitric oxide during diagnostic right heart catheterization. A positive acute response was defined as a reduction in mean pulmonary arterial pressure (PAP) ≥10 mmHg to an absolute level of mean PAP <40 mmHg without a decrease in cardiac output. Among a total of 60 IPAH patients included for analysis, 9 (15%) showed a positive acute response to acute vasodilator testing. Acute responders showed significantly lower peak velocity of a tricuspid regurgitation jet on echocardiography (4.1±0.3 m/s vs. 4.6±0.6 m/s; P=0.01) and significantly lower mean PAP hemodynamically (47±10 mmHg vs. 63±17 mmHg; P=0.003) than non-responders at baseline. The survival rate of acute responders was 88% at 1, 3, 5, and 10 yr, respectively, which was significantly higher than that of non-responders (85%, 71%, 55%, and 40%, respectively; P=0.029). In conclusion, Korean IPAH patients with vasoreactivity showed better baseline hemodynamic features and survival than those without vasoreactivity. We aimed to identify a vasoreactive subset of patients with idiopathic pulmonary arterialhypertension (IPAH) in Korea and to show their clinical characteristics and prognosis. Dataon patients who were diagnosed with IPAH at Asan Medical Center between January 1994and March 2013 were retrospectively collected. Acute vasodilator testing was performedwith inhaled nitric oxide during diagnostic right heart catheterization. A positive acuteresponse was defined as a reduction in mean pulmonary arterial pressure (PAP) ≥ 10 mmHgto an absolute level of mean PAP < 40 mmHg without a decrease in cardiac output. Among a total of 60 IPAH patients included for analysis, 9 (15%) showed a positive acuteresponse to acute vasodilator testing. Acute responders showed significantly lower peakvelocity of a tricuspid regurgitation jet on echocardiography (4.1 ± 0.3 m/s vs. 4.6 ± 0.6m/s; P = 0.01) and significantly lower mean PAP hemodynamically (47 ± 10 mmHg vs. 63 ± 17 mmHg; P = 0.003) than non-responders at baseline. The survival rate of acuteresponders was 88% at 1, 3, 5, and 10 yr, respectively, which was significantly higher thanthat of non-responders (85%, 71%, 55%, and 40%, respectively; P = 0.029). In conclusion,Korean IPAH patients with vasoreactivity showed better baseline hemodynamic featuresand survival than those without vasoreactivity. KCI Citation Count: 2 We aimed to identify a vasoreactive subset of patients with idiopathic pulmonary arterial hypertension (IPAH) in Korea and to show their clinical characteristics and prognosis. Data on patients who were diagnosed with IPAH at Asan Medical Center between January 1994 and March 2013 were retrospectively collected. Acute vasodilator testing was performed with inhaled nitric oxide during diagnostic right heart catheterization. A positive acute response was defined as a reduction in mean pulmonary arterial pressure (PAP) ≥10 mmHg to an absolute level of mean PAP <40 mmHg without a decrease in cardiac output. Among a total of 60 IPAH patients included for analysis, 9 (15%) showed a positive acute response to acute vasodilator testing. Acute responders showed significantly lower peak velocity of a tricuspid regurgitation jet on echocardiography (4.1±0.3 m/s vs. 4.6±0.6 m/s; P=0.01) and significantly lower mean PAP hemodynamically (47±10 mmHg vs. 63±17 mmHg; P=0.003) than non-responders at baseline. The survival rate of acute responders was 88% at 1, 3, 5, and 10 yr, respectively, which was significantly higher than that of non-responders (85%, 71%, 55%, and 40%, respectively; P=0.029). In conclusion, Korean IPAH patients with vasoreactivity showed better baseline hemodynamic features and survival than those without vasoreactivity. |
Author | Ahn, Jee Hwan Lee, Jae Seung Lee, Sang-Do Lee, Jung Su Oh, Yeon-Mok Hong, Sun In Kang, Byung Ju |
AuthorAffiliation | 3 Center for Pulmonary Hypertension and Venous Thromboembolism, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea 2 Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea 1 Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea |
AuthorAffiliation_xml | – name: 1 Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea – name: 2 Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea – name: 3 Center for Pulmonary Hypertension and Venous Thromboembolism, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea |
Author_xml | – sequence: 1 givenname: Jee Hwan orcidid: 0000-0001-6653-998X surname: Ahn fullname: Ahn, Jee Hwan organization: Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea – sequence: 2 givenname: Byung Ju orcidid: 0000-0002-1396-7398 surname: Kang fullname: Kang, Byung Ju organization: Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea – sequence: 3 givenname: Sun In orcidid: 0000-0003-2575-2084 surname: Hong fullname: Hong, Sun In organization: Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea – sequence: 4 givenname: Jung Su orcidid: 0000-0001-5644-0150 surname: Lee fullname: Lee, Jung Su organization: Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea – sequence: 5 givenname: Jae Seung orcidid: 0000-0003-4130-1486 surname: Lee fullname: Lee, Jae Seung organization: Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea., Center for Pulmonary Hypertension and Venous Thromboembolism, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea – sequence: 6 givenname: Yeon-Mok orcidid: 0000-0003-0116-4683 surname: Oh fullname: Oh, Yeon-Mok organization: Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea – sequence: 7 givenname: Sang-Do orcidid: 0000-0001-8189-4509 surname: Lee fullname: Lee, Sang-Do organization: Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea., Center for Pulmonary Hypertension and Venous Thromboembolism, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25469067$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001935478$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp9Uklv1DAUtlARXeAfIOQjl4R4TcwBaRgBHVGJCgpXy3Fsxp3EDnYy0og_j9OhbAdOfsu32M_vHJz44A0AT1FVEkL5i9vdkEpcIVpiUSJcIs7ZA3CGmGgKTlh9kuMKoaIRhJ6C85RuqwozhskjcIoZ5aLi9Rn4vu6dd1r1cL1VUenJRJcmpxNUvoOf5rh3-9wMFr4P0SgPN50Lo5q2TsPruR-CV_EAV3HhZdzlYTQ59skFD6_V5IyfEnytkulgrnxRaVHRk9u76fAYPLSqT-bJz_MCfH775mZ9WVx9eLdZr64KTSmaiprilthOsJwyLWhNqG5sLnTMKKOIVpzVLaPEWtQaYZVVOme0Fhq1tqnIBXh-1PXRyp12Mih3d34Nchfl6uPNRrIa55ll6KsjdJzbwXQ6Xz-qXo7RDfmdd8S_O95ts8xeUkwb1jS_vcYYvs0mTXJwSZu-V96EOUnEsRCcccQz9NmfXr9M7j8nA14eATqGlKKxUrspzzQs1q6XqJLLJshlE-SyCRILibBcNiGT6T_ke_3_0n4A_1i8qg |
CitedBy_id | crossref_primary_10_3346_jkms_2015_30_10_1429 crossref_primary_10_3904_kjim_2019_185 |
Cites_doi | 10.1016/j.jacc.2009.01.004 10.7326/0003-4819-107-2-216 10.1016/S0735-1097(03)00463-7 10.1016/j.jacc.2009.04.012 10.3346/jkms.2013.28.8.1200 10.1016/j.jacc.2009.04.017 10.1183/09031936.98.12020265 10.1164/rccm.200510-1668OC 10.1016/j.jacc.2013.10.029 10.1378/chest.09-1140 10.1093/eurheartj/ehp297 10.1183/09031936.00169608 10.3346/jkms.2012.27.8.901 10.1378/chest.11-3060 10.1164/ajrccm/140.6.1623 10.1056/NEJM199207093270203 10.1378/chest.111.1.36 10.2169/internalmedicine.51.8162 10.1161/CIRCULATIONAHA.104.488486 10.1378/chest.06-2913 |
ContentType | Journal Article |
Copyright | 2014 The Korean Academy of Medical Sciences. 2014 |
Copyright_xml | – notice: 2014 The Korean Academy of Medical Sciences. 2014 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ACYCR |
DOI | 10.3346/jkms.2014.29.12.1665 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1598-6357 |
EndPage | 1671 |
ExternalDocumentID | oai_kci_go_kr_ARTI_572357 PMC4248588 25469067 10_3346_jkms_2014_29_12_1665 |
Genre | Journal Article |
GeographicLocations | Republic of Korea |
GeographicLocations_xml | – name: Republic of Korea |
GroupedDBID | --- 29K 2WC 3O- 5-W 53G 5GY 8JR 8XY 9ZL AAYXX ADBBV ADRAZ AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION CS3 D-I DIK DU5 E3Z EBS EF. EJD F5P FRP GROUPED_DOAJ GX1 HYE KQ8 M48 O5R O5S OK1 OVT PGMZT RNS RPM TR2 W2D XSB CGR CUY CVF ECM EIF NPM 7X8 5PM 08R ACYCR M~E |
ID | FETCH-LOGICAL-c441t-742b3fd95c445c94734c8ffd9d5eaea3ca657b543ff1be9fafac543479c1bf803 |
IEDL.DBID | M48 |
ISSN | 1011-8934 1598-6357 |
IngestDate | Tue Nov 21 21:40:42 EST 2023 Thu Aug 21 14:04:37 EDT 2025 Fri Jul 11 01:22:50 EDT 2025 Thu Apr 03 07:01:06 EDT 2025 Tue Jul 01 01:44:55 EDT 2025 Thu Apr 24 23:07:40 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | Calcium Channel Blockers Vasodilator Agents Hypertension, Pulmonary Survival Rate |
Language | English |
License | http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c441t-742b3fd95c445c94734c8ffd9d5eaea3ca657b543ff1be9fafac543479c1bf803 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Jee Hwan Ahn and Byung Ju Kang contributed equally to this work. G704-000345.2014.12.12.020 |
ORCID | 0000-0001-6653-998X 0000-0002-1396-7398 0000-0003-0116-4683 0000-0001-5644-0150 0000-0003-4130-1486 0000-0001-8189-4509 0000-0003-2575-2084 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3346/jkms.2014.29.12.1665 |
PMID | 25469067 |
PQID | 1629965616 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_572357 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4248588 proquest_miscellaneous_1629965616 pubmed_primary_25469067 crossref_citationtrail_10_3346_jkms_2014_29_12_1665 crossref_primary_10_3346_jkms_2014_29_12_1665 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-12-01 |
PublicationDateYYYYMMDD | 2014-12-01 |
PublicationDate_xml | – month: 12 year: 2014 text: 2014-12-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Journal of Korean medical science |
PublicationTitleAlternate | J Korean Med Sci |
PublicationYear | 2014 |
Publisher | The Korean Academy of Medical Sciences 대한의학회 |
Publisher_xml | – name: The Korean Academy of Medical Sciences – name: 대한의학회 |
References | Humbert (10.3346/jkms.2014.29.12.1665_ref8) 2006; 173 Sitbon (10.3346/jkms.2014.29.12.1665_ref12) 1998; 12 McLaughlin (10.3346/jkms.2014.29.12.1665_ref1) 2009; 53 Barst (10.3346/jkms.2014.29.12.1665_ref21) 2009; 54 Jing (10.3346/jkms.2014.29.12.1665_ref15) 2009; 33 Rich (10.3346/jkms.2014.29.12.1665_ref4) 1992; 327 Simonneau (10.3346/jkms.2014.29.12.1665_ref2) 2009; 54 Jing (10.3346/jkms.2014.29.12.1665_ref13) 2007; 132 Sakao (10.3346/jkms.2014.29.12.1665_ref14) 2012; 51 Park (10.3346/jkms.2014.29.12.1665_ref20) 2013; 28 Sitbon (10.3346/jkms.2014.29.12.1665_ref5) 2005; 111 Galiè (10.3346/jkms.2014.29.12.1665_ref6) 2009; 30 Simonneau (10.3346/jkms.2014.29.12.1665_ref11) 2013; 62 McLaughlin (10.3346/jkms.2014.29.12.1665_ref18) 2013; 143 Rich (10.3346/jkms.2014.29.12.1665_ref3) 1987; 107 Barst (10.3346/jkms.2014.29.12.1665_ref19) 2003; 41 Tueller (10.3346/jkms.2014.29.12.1665_ref9) 2008; 138 Weir (10.3346/jkms.2014.29.12.1665_ref7) 1989; 140 Murata (10.3346/jkms.2014.29.12.1665_ref10) 1997; 111 Badesch (10.3346/jkms.2014.29.12.1665_ref16) 2010; 137 Joo (10.3346/jkms.2014.29.12.1665_ref17) 2012; 27 9727772 - Eur Respir J. 1998 Aug;12(2):265-70 22876057 - J Korean Med Sci. 2012 Aug;27(8):901-6 19389575 - J Am Coll Cardiol. 2009 Apr 28;53(17):1573-619 23037462 - Intern Med. 2012;51(19):2721-6 17400671 - Chest. 2007 Aug;132(2):373-9 19213781 - Eur Respir J. 2009 Jun;33(6):1354-60 19555861 - J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S78-84 23960448 - J Korean Med Sci. 2013 Aug;28(8):1200-6 8995990 - Chest. 1997 Jan;111(1):36-43 19555858 - J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S43-54 3605900 - Ann Intern Med. 1987 Aug;107(2):216-23 12821234 - J Am Coll Cardiol. 2003 Jun 18;41(12):2119-25 15939821 - Circulation. 2005 Jun 14;111(23):3105-11 22910999 - Chest. 2013 Feb 1;143(2):324-32 1603139 - N Engl J Med. 1992 Jul 9;327(2):76-81 19837821 - Chest. 2010 Feb;137(2):376-87 24355639 - J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D34-41 19713419 - Eur Heart J. 2009 Oct;30(20):2493-537 18587690 - Swiss Med Wkly. 2008 Jun 28;138(25-26):379-84 16456139 - Am J Respir Crit Care Med. 2006 May 1;173(9):1023-30 2690706 - Am Rev Respir Dis. 1989 Dec;140(6):1623-30 |
References_xml | – volume: 53 start-page: 1573 year: 2009 ident: 10.3346/jkms.2014.29.12.1665_ref1 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2009.01.004 – volume: 107 start-page: 216 year: 1987 ident: 10.3346/jkms.2014.29.12.1665_ref3 publication-title: Ann Intern Med doi: 10.7326/0003-4819-107-2-216 – volume: 41 start-page: 2119 year: 2003 ident: 10.3346/jkms.2014.29.12.1665_ref19 publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(03)00463-7 – volume: 54 start-page: S43 year: 2009 ident: 10.3346/jkms.2014.29.12.1665_ref2 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2009.04.012 – volume: 28 start-page: 1200 year: 2013 ident: 10.3346/jkms.2014.29.12.1665_ref20 publication-title: J Korean Med Sci doi: 10.3346/jkms.2013.28.8.1200 – volume: 54 start-page: S78 year: 2009 ident: 10.3346/jkms.2014.29.12.1665_ref21 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2009.04.017 – volume: 12 start-page: 265 year: 1998 ident: 10.3346/jkms.2014.29.12.1665_ref12 publication-title: Eur Respir J doi: 10.1183/09031936.98.12020265 – volume: 173 start-page: 1023 year: 2006 ident: 10.3346/jkms.2014.29.12.1665_ref8 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200510-1668OC – volume: 138 start-page: 379 year: 2008 ident: 10.3346/jkms.2014.29.12.1665_ref9 publication-title: Swiss Med Wkly – volume: 62 start-page: D34 year: 2013 ident: 10.3346/jkms.2014.29.12.1665_ref11 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.10.029 – volume: 137 start-page: 376 year: 2010 ident: 10.3346/jkms.2014.29.12.1665_ref16 publication-title: Chest doi: 10.1378/chest.09-1140 – volume: 30 start-page: 2493 year: 2009 ident: 10.3346/jkms.2014.29.12.1665_ref6 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehp297 – volume: 33 start-page: 1354 year: 2009 ident: 10.3346/jkms.2014.29.12.1665_ref15 publication-title: Eur Respir J doi: 10.1183/09031936.00169608 – volume: 27 start-page: 901 year: 2012 ident: 10.3346/jkms.2014.29.12.1665_ref17 publication-title: J Korean Med Sci doi: 10.3346/jkms.2012.27.8.901 – volume: 143 start-page: 324 year: 2013 ident: 10.3346/jkms.2014.29.12.1665_ref18 publication-title: Chest doi: 10.1378/chest.11-3060 – volume: 140 start-page: 1623 year: 1989 ident: 10.3346/jkms.2014.29.12.1665_ref7 publication-title: Am Rev Respir Dis doi: 10.1164/ajrccm/140.6.1623 – volume: 327 start-page: 76 year: 1992 ident: 10.3346/jkms.2014.29.12.1665_ref4 publication-title: N Engl J Med doi: 10.1056/NEJM199207093270203 – volume: 111 start-page: 36 year: 1997 ident: 10.3346/jkms.2014.29.12.1665_ref10 publication-title: Chest doi: 10.1378/chest.111.1.36 – volume: 51 start-page: 2721 year: 2012 ident: 10.3346/jkms.2014.29.12.1665_ref14 publication-title: Intern Med doi: 10.2169/internalmedicine.51.8162 – volume: 111 start-page: 3105 year: 2005 ident: 10.3346/jkms.2014.29.12.1665_ref5 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.104.488486 – volume: 132 start-page: 373 year: 2007 ident: 10.3346/jkms.2014.29.12.1665_ref13 publication-title: Chest doi: 10.1378/chest.06-2913 – reference: 3605900 - Ann Intern Med. 1987 Aug;107(2):216-23 – reference: 17400671 - Chest. 2007 Aug;132(2):373-9 – reference: 9727772 - Eur Respir J. 1998 Aug;12(2):265-70 – reference: 22910999 - Chest. 2013 Feb 1;143(2):324-32 – reference: 2690706 - Am Rev Respir Dis. 1989 Dec;140(6):1623-30 – reference: 1603139 - N Engl J Med. 1992 Jul 9;327(2):76-81 – reference: 24355639 - J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D34-41 – reference: 18587690 - Swiss Med Wkly. 2008 Jun 28;138(25-26):379-84 – reference: 19213781 - Eur Respir J. 2009 Jun;33(6):1354-60 – reference: 19555861 - J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S78-84 – reference: 19555858 - J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S43-54 – reference: 19713419 - Eur Heart J. 2009 Oct;30(20):2493-537 – reference: 22876057 - J Korean Med Sci. 2012 Aug;27(8):901-6 – reference: 8995990 - Chest. 1997 Jan;111(1):36-43 – reference: 15939821 - Circulation. 2005 Jun 14;111(23):3105-11 – reference: 23960448 - J Korean Med Sci. 2013 Aug;28(8):1200-6 – reference: 16456139 - Am J Respir Crit Care Med. 2006 May 1;173(9):1023-30 – reference: 19837821 - Chest. 2010 Feb;137(2):376-87 – reference: 12821234 - J Am Coll Cardiol. 2003 Jun 18;41(12):2119-25 – reference: 19389575 - J Am Coll Cardiol. 2009 Apr 28;53(17):1573-619 – reference: 23037462 - Intern Med. 2012;51(19):2721-6 |
SSID | ssj0025523 |
Score | 2.027469 |
Snippet | We aimed to identify a vasoreactive subset of patients with idiopathic pulmonary arterial hypertension (IPAH) in Korea and to show their clinical... We aimed to identify a vasoreactive subset of patients with idiopathic pulmonary arterialhypertension (IPAH) in Korea and to show their clinical... |
SourceID | nrf pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1665 |
SubjectTerms | Adolescent Adult Aged Female Humans Hypertension, Pulmonary - diagnosis Hypertension, Pulmonary - mortality Hypertension, Pulmonary - physiopathology Male Middle Aged Original Prevalence Prognosis Reproducibility of Results Republic of Korea - epidemiology Risk Factors Sensitivity and Specificity Survival Rate Vascular Resistance - drug effects Vasodilator Agents Young Adult 의학일반 |
Title | Clinical Characteristics and Survival of Korean Idiopathic Pulmonary Arterial Hypertension Patients Based on Vasoreactivity |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25469067 https://www.proquest.com/docview/1629965616 https://pubmed.ncbi.nlm.nih.gov/PMC4248588 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001935478 |
Volume | 29 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Journal of Korean Medical Science, 2014, 12(12), 195, pp.1665-1671 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELZ2FwlxQbwpj8pIXLOqYzuxDwjBilXLqmglKNqb5fixVC0OpK3Eij_PTJJWFC2CU5TUmbiZSeb7YvsbQl5GWwJfiz5TWvJMlKOQacClGYuQf1zllXC4UHj6oRjPxPsLeXFAtjVb-xu4upbaYT2pWbM8_vH96jU88K-QcXIcoVx8ReFtJo5zjd_2WFHIQ3IDclOBdGwqduMKgJ_zbso9Y9A7LrrFdH-1spesDlMTr8Ohf06n_C0_nd4ht3tgSd90kXCXHIR0j9yc9kPn98nPXgF0SU_2NZqpTZ5-3MArA4KO1pGe1QAkE534ed3WK3b0fLOEaLXNFZpvQ5aOgb827ez3OtHzTpx1Rd9CTvQUjny2K7TiutoUD8js9N2nk3HWV17IHMCjdQZ8ueLRawm70mlRcuFUhANeBhssd7aQZSUFj5FVQUcbrcM1qqV2rIpqxB-So1Sn8JhQWSEJwhWtABbkyCqvHJhQMfi88nkxIHx7i43rZcmxOsbSAD1Bxxh0jEHHmFwblht0zIBku7O-dbIc_2j_ArxnFm5uUE8bt5e1WTQGWMPEyBJFf6DN1rcGnjEcOLEp1JsVWICkDcCXQW8fdb7eXRXrCWhI-QNS7kXBrgFeb_-XNP_S6ngLlJNT6sl_9O0puYX_qJtH84wcrZtNeA5oaF0NgQdMzobtt4RhG-y_AFalDAM |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+Characteristics+and+Survival+of+Korean+Idiopathic+Pulmonary+Arterial+Hypertension+Patients+Based+on+Vasoreactivity&rft.jtitle=Journal+of+Korean+medical+science&rft.au=%EC%95%88%EC%A7%80%ED%99%98&rft.au=%EA%B0%95%EB%B3%91%EC%A3%BC&rft.au=%ED%99%8D%EC%84%A0%EC%9D%B8&rft.au=%EC%9D%B4%EC%A0%95%EC%88%98&rft.date=2014-12-01&rft.pub=%EB%8C%80%ED%95%9C%EC%9D%98%ED%95%99%ED%9A%8C&rft.issn=1011-8934&rft.eissn=1598-6357&rft.spage=1665&rft.epage=1671&rft_id=info:doi/10.3346%2Fjkms.2014.29.12.1665&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_572357 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1011-8934&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1011-8934&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1011-8934&client=summon |